When CD200 expression was evaluated, it was moderate to strong in 95.8% of the CLL patients (3.6% had negative expression), whereas it was dimly expressed only in 2 MCL patients (6.1%) (p<0.001; Table 2). The gene discussed is CD200; the disease is mantle cell lymphoma.